Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 Diabetes.
Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 Diabetes.
Journal: medRxiv : the preprint server for health sciences
Published: January 02, 2026
Differential effects of subcutaneous and sublingual immunotherapy on timothy grass-specific TH2 CD4+ T-cell subsets.
Journal: The Journal of allergy and clinical immunology
Published: October 21, 2025
Dosing Reactions and Missed Doses Affect Peanut Oral Immunotherapy Outcomes.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 24, 2025
Gut microbial bile and amino acid metabolism associate with peanut oral immunotherapy failure.
Journal: Nature communications
Published: February 25, 2025
Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 16, 2024
Enhanced Gut Microbiome Capacity for Amino Acid Metabolism is associated with Peanut Oral Immunotherapy Failure.
Journal: medRxiv : the preprint server for health sciences
Published: July 29, 2024
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
Journal: The Journal of allergy and clinical immunology
Published: September 28, 2022
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
Journal: The Journal of allergy and clinical immunology
Published: July 28, 2022
Last Updated: 09/26/2026